Source: http://news.consumerreports.org/health/2011/06/fda-warns-of-bladder-cancer-risk-with-actos.html
lamictal withdrawal lamictal generic lamictal dosage side effects of lamictal
Sunday, June 26, 2011
FDA warns of bladder cancer risk with Actos
The diabetes drug pioglitazone (Actos) increases the risk of bladder cancer in people who take it for a year or longer, the Food and Drug Administration announced yesterday. The warning applies to all drugs containing pioglitazone, including Actoplus Met, Actoplus...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment